MeVis Medical Solutions AG (FRA:M3V)

Market Cap	43.32M -4.0%
Revenue (ttm)	15.48M -6.9%
Net Income	1.38M -67.8%
EPS	0.76 -67.8%
Shares Out	n/a
PE Ratio	31.29
Forward PE	n/a
Dividend	0.95 (4.03%)
Ex-Dividend Date	Mar 20, 2026

Volume	n/a
Open	23.20
Previous Close	23.40
Day's Range	23.20 - 23.40
52-Week Range	20.00 - 26.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About FRA:M3V

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sono...

• Industry: Prepackaged Software
• Founded: 1997
• Employees: 127
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M3V

Financial Performance

In fiscal year 2025, FRA:M3V's revenue was 16.06 million, a decrease of -5.36% compared to the previous year's 16.97 million. Earnings were 3.17 million, a decrease of -30.58%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error